ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Notably, this leukemia animal model not only mimics a gene therapy application in CML patients but also indicates that one course of ABL-targeted CRISPR/Cas9 virus treatment is sufficiently effective to suppress leukemia cell growth.